Tag Archives: antiretroviral drugs

Global Fund changes highlight opportunities, challenges

By on .

The Kaiser Family Foundation’s panel talk on changes at The Global Fund to Fight AIDS, Tuberculosis and Malaria, focused on the impact of reorganization at the charity at a time when scientific progress offers unprecedented chances for inroads against the diseases. Panelists Joanne Carter, executive director of RESULTS/RESULTS EDUCATION FUND, J. Stephen Morrison, senior vice [...]

Looking toward Vienna: Dan Kuritzkes, MD

By on .

The International AIDS Conference starts up in less than a week in Vienna, Austria.  ScienceSpeaks is gathering thoughts from leaders in the field HIV/AIDS treatment, research and advocacy in the question and answer series “Looking toward Vienna.” Daniel R. Kuritzkes, MD, is a Professor of Medicine at Harvard Medical School. He is also the Head [...]

For men and women in Africa, rectal microbicides are crucial

By on .

Here at the Microbicides 2010 conference in Pittsburgh I got a chance to talk with Dr. Gita Ramjee, one of the top researchers in the field, about the most exciting scientific challenges being discussed at the meeting.  Dr Ramjee is the Director of the HIV Prevention Research Unit at the South African Medical Research Council.  [...]

Don't miss the April 1 online presentation on treatment as prevention

By on .

Can ARV treatment be used to prevent HIV infection?  What are the implications?  How far along is the science? Mark your calendar to hear an online presentation and discussion on treatment as prevention, Thursday, April 1 at 10am EDT. You can ask questions via the web as it is taking place, and you can also [...]

Reactions to the New CSIS Report on "Smart Global Health Policy"

By on .

The Center for Strategic and International Studies yesterday unveiled  a new “must-read” report for global health advocates, “Smart Global Health Policy.” While a panel at the Congressionally-chartered Institute of Medicine, made up primarily of scientists, issued recommendations on US global health policy last year, the CSIS panel is the first to involve high-level business leaders [...]

HIV/AIDS Physician-Scientists, Advocates Call for Bold HIV Treatment Goals for PEPFAR

By on .

Physician-scientists working on the frontlines of the HIV/AIDS epidemic today urged the White House to set bold new HIV treatment targets for PEPFAR, the U.S. President’s Emergency Plan for AIDS Relief. The Center for Global Health Policy joined with a coalition of other organizations—including HealthGAP, amfAR (the Foundation for AIDS Research), the Treatment Action Group, [...]

WHO Bulletin Examines Using ART to Prevent HIV Transmission

By on .

The World Health Organization’s latest bulletin is a must-read for experts and advocates working on global AIDS, delving into the hot topic of preventing HIV transmission with antiretroviral drugs and noting upcoming WHO action on this issue in the coming months. The bulletin, authored by Kevin M De Cock and others in the WHO’s Department [...]

Key Decision on TB and AIDS Funding Looms in the U.S. House

By on .

Editor’s Note: We will be blogging today about the House Appropriations subcommittee meeting, filing an update on funding levels for global health programs. So check back to see what happens! At last week’s HIV/AIDS Implementers’ Meeting in Namibia, participants expressed deep concern about the commitment among donor nations to maintaining the momentum in the global fight [...]

Further budget analysis from Global Center

By on .

Yesterday we received more information about the budget proposal from President Obama.  There are some new details, such as his proposal to flat-fund US backing for the Global Fund.  His proposal does not add up, I am sorry to say, and it is not consistent with the Hyde-Lantos legislation the President co-sponsored last year.  Why [...]

Drug Shortages Reach Crisis Levels In South African Province

By on .

In the past week, three stories about severe TB or HIV drug shortages have landed in our inbox. From Uganda to Burma to South Africa, TB and HIV patients are being forced to go without desperately needed medications. The latest story is the most troubling. An article in the Globe and Mail recounts the story [...]